Da An Gene Co Ltd of Sun Yat-Sen University - Asset Resilience Ratio

Latest as of September 2025: 4.35%

Da An Gene Co Ltd of Sun Yat-Sen University (002030) has an Asset Resilience Ratio of 4.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Da An Gene Co Ltd of Sun Yat-Sen Univers balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥396.00 Million
≈ $57.95 Million USD Cash + Short-term Investments

Total Assets

CN¥9.09 Billion
≈ $1.33 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Da An Gene Co Ltd of Sun Yat-Sen University's Asset Resilience Ratio has changed over time. See Da An Gene Co Ltd of Sun Yat-Sen Univers shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Da An Gene Co Ltd of Sun Yat-Sen University's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002030 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥396.00 Million 4.35%
Total Liquid Assets CN¥396.00 Million 4.35%

Asset Resilience Insights

  • Limited Liquidity: Da An Gene Co Ltd of Sun Yat-Sen University maintains only 4.35% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Da An Gene Co Ltd of Sun Yat-Sen University Industry Peers by Asset Resilience Ratio

Compare Da An Gene Co Ltd of Sun Yat-Sen University's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Fortress Biotech Inc
NASDAQ:FBIO
Biotechnology 11.59%
Summit Therapeutics PLC
NASDAQ:SMMT
Biotechnology 0.00%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Biotechnology 0.58%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
BrightGene Bio Medical Technology C
SHG:688166
Biotechnology 1.00%
BioArctic AB (publ)
ST:BIOA-B
Biotechnology 72.35%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%

Annual Asset Resilience Ratio for Da An Gene Co Ltd of Sun Yat-Sen University (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Da An Gene Co Ltd of Sun Yat-Sen University.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.66% CN¥63.00 Million
≈ $9.22 Million
CN¥9.58 Billion
≈ $1.40 Billion
-12.05pp
2023-12-31 12.71% CN¥1.40 Billion
≈ $204.90 Million
CN¥11.02 Billion
≈ $1.61 Billion
+9.45pp
2022-12-31 3.26% CN¥480.90 Million
≈ $70.37 Million
CN¥14.76 Billion
≈ $2.16 Billion
-0.42pp
2021-12-31 3.68% CN¥380.01 Million
≈ $55.61 Million
CN¥10.34 Billion
≈ $1.51 Billion
-9.58pp
2020-12-31 13.25% CN¥888.00 Million
≈ $129.94 Million
CN¥6.70 Billion
≈ $980.42 Million
+12.12pp
2019-12-31 1.13% CN¥40.24 Million
≈ $5.89 Million
CN¥3.56 Billion
≈ $521.18 Million
-22.70pp
2018-12-31 23.83% CN¥873.04 Million
≈ $127.75 Million
CN¥3.66 Billion
≈ $536.06 Million
+25.80pp
2017-12-31 -1.97% CN¥-91.30 Million
≈ $-13.36 Million
CN¥4.64 Billion
≈ $679.24 Million
-2.18pp
2016-12-31 0.22% CN¥9.00 Million
≈ $1.32 Million
CN¥4.14 Billion
≈ $605.76 Million
-1.22pp
2015-12-31 1.43% CN¥43.60 Million
≈ $6.38 Million
CN¥3.04 Billion
≈ $445.10 Million
--
pp = percentage points

About Da An Gene Co Ltd of Sun Yat-Sen University

SHE:002030 China Biotechnology
Market Cap
$1.19 Billion
CN¥8.11 Billion CNY
Market Cap Rank
#8372 Global
#2151 in China
Share Price
CN¥5.78
Change (1 day)
-0.17%
52-Week Range
CN¥5.68 - CN¥7.71
All Time High
CN¥25338.45
About

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more